GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the compounding rule is doing its job and people should stop complaining — 10 comments in the full submission. View in context.
70
c/compounding·submitted 1 months ago by u/anya_antonsen

[Meta] the compounding rule is doing its job and people should stop complaining

Pricingbranch of 8 comments

telehealth. That is the whole post, but I will justify it. Everything else people worry about in c/coldchain is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort telehealth out first, and almost nobody does. I say this having got it wrong for 2 months. My fasting…

Read the full submission and all 10 comments →

This branch

8 comments, started 1 months ago
u/hugo_bergstrom18 points·1 months ago·edited

Are we talking 503A or 503B?

replysharereportpermalink
u/burned_once_twice6 points·1 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/naomi_erdogan-21 points·1 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/pavel_kravchenko1 point·1 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink
[removed]4 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/burned_once_twice5 points·1 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/medutest_mel2 points·1 months ago

Small correction: the trial was 3 weeks, not 13. Does not change your point but people will quote it.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →